vimarsana.com

Latest Breaking News On - Peterm eriksen - Page 1 : vimarsana.com

Notice convening the Annual General Meeting in BioPorto

Notice convening the Annual General Meeting in BioPorto A/S

Settlement - Purchase of shares

finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

BioPorto A/S says first quarter revenue increased by 33% driven by strong sales of antibodies and its NGAL test

The Danish company has forecast overall revenue of approximately DKK 30 (US$4.9 million) for 2021 BioPorto said that, in the first quarter, it pushed hard on clinical programs for its NGAL Test for pediatric acute kidney injury and a coronavirus test BioPorto A/S (CPH:BIOPOR) (FRA:2P4) has shared an interim report which showed that its first-quarter 2021 revenue grew by 33% driven by “strong sales of antibodies” and its flagship NGAL acute kidney-injury test.  The in-vitro diagnostic company based in Hellerup, Denmark, said that revenue from product sales of its proprietary NGAL Test remained at last year’s “high level” with a “solid performance” in the United States.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.